**Question:** All of the following are true regarding chronic myeloid leukemia, except?

A. Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the presence of a Philadelphia chromosome.
B. The Philadelphia chromosome is a reciprocal translocation involving chromosomes 9 and 22, resulting in the fusion protein BCR-ABL1.
C. The presence of the BCR-ABL1 fusion protein leads to uncontrolled proliferation of myeloid cells.
D. The Philadelphia chromosome is a result of a balanced chromosomal translocation.

**Correct Answer: D.**

**Core Concept:**
Chronic myeloid leukemia (CML) is a type of cancer affecting blood cells, particularly the myeloid lineage. It is characterized by the presence of a specific chromosomal abnormality, the Philadelphia chromosome, which is a result of a reciprocal translocation involving chromosomes 9 and 22. The translocation leads to the fusion of the breakpoint cluster region (BCR) gene on chromosome 9 with the Abelson (ABL) gene on chromosome 22, forming the BCR-ABL1 fusion protein.

**Why the Correct Answer is Right:**
The Philadelphia chromosome is not a result of a balanced chromosomal translocation, which would involve two non-overlapping segments of each chromosome involved in the translocation. In CML, the chromosomes involved (chromosomes 9 and 22) are not involved in a balanced translocation. Instead, the translocation involves the juxtaposition of the BCR gene on chromosome 9 with the ABL gene on chromosome 22, leading to the formation of the BCR-ABL1 fusion protein. This protein is a tyrosine kinase that results in uncontrolled proliferation of myeloid cells, ultimately causing the symptoms and signs associated with CML.

**Why Each Wrong Option is Incorrect:**

**A.** The presence of the Philadelphia chromosome is a hallmark of CML and directly contributes to the disease pathogenesis. The statement that the Philadelphia chromosome is a result of a balanced chromosomal translocation is incorrect.

**B.** The Philadelphia chromosome is indeed a result of a reciprocal chromosomal translocation, but the specific details mentioned (involvement of chromosomes 9 and 22) are not relevant to the explanation of the Philadelphia chromosome. The key point is that the translocation involves the BCR and ABL genes, leading to the fusion protein BCR-ABL1.

**C.** The BCR-ABL1 fusion protein plays a crucial role in the pathogenesis of CML by promoting uncontrolled proliferation of myeloid cells. This option highlights the correct aspect of the Philadelphia chromosome's role in CML.

**D.** This option incorrectly states that the Philadelphia chromosome is a result of a balanced chromosomal translocation, which is not relevant to the explanation of the Philadelphia chromosome in chronic myeloid leukemia. The key point is that the translocation involves the BCR and ABL genes, leading to the fusion protein BCR-ABL1.

**Clinical Pearl:**
The Philadelphia chromosome is a specific chromosomal abnormality in chronic myeloid leukemia, characterized by the fusion of the BCR